Artelo Biosciences Advances ART12.11 Following CBD Research Review
Solana Beach, Calif., July 22, 2026 Artelo Biosciences announced the publication of a peer-reviewed review article in the British...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Solana Beach, Calif., July 22, 2026 Artelo Biosciences announced the publication of a peer-reviewed review article in the British...
HAVERHILL, United Kingdom, July 6, 2026 Codis announced an agreement to acquire Catalent Pharma Solutions’ Nottingham, UK facility, a...
PARIS, France & CAMBRIDGE, USA, April 20, 2026 Nanobiotix has unveiled promising preclinical data demonstrating that its Nanoprimer technology...
JUPITER, Florida, November 5, 2025 — Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage biopharmaceutical company, announced that the U.S....
FORT LAUDERDALE, Fla., Oct. 3, 2025 — Synevit released a technical explainer on enteric-coated vitamins, outlining how delayed release...
